Mycophenolate Mofetil for Drug-Induced Vanishing Bile Duct Syndrome

World Journal of Gastroenterology - China
doi 10.3748/wjg.13.6087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Baishideng Publishing Group Inc.

Related search

Idiosyncratic Drug-Induced Liver Injury Associated With Bile Duct Loss and Vanishing Bile Duct Syndrome: Rare but Has Severe Consequences

Hepatology
MedicineHepatology
2017English

Mycophenolate Mofetil Induced Remission in Steroid-Refractory Autoimmune Hemolytic Anemia

Meandros Medical and Dental Journal
2018English

Nonlinear Relationship Between Mycophenolate Mofetil Dose and Mycophenolic Acid Exposure: Implications for Therapeutic Drug Monitoring

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2010English

Prospects for Using Mycophenolate Mofetil in Diffuse Scleroderma

Modern Rheumatology Journal
2009English

Hepatic Ductopenia and Vanishing Bile Duct Syndrome Following Anabolic Androgenic Steroid Use: A Case Report and Literature Review.

Canadian Journal of General Internal Medicine
2018English

A Case of Vanishing Bile Duct Syndrome Complicated With Toxic Epidermal Necrolysis Performed Liver Biopsy Three Times Subsequently

Acta Hepatologica Japonica
Hepatology
2013English

Transient Improvement of Hypertension-Induced Chronic Renal Failure With Mycophenolate Mofetil Treatment

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2006English

Down-Regulation of Multiple Low Dose Streptozotocin-Induced Diabetes by Mycophenolate Mofetil

Clinical and Experimental Immunology
AllergyImmunology
2002English

Cyclophosphamide Versus Mycophenolate Mofetil for Initial Treatment of Lupus Nephritis

Kidney International
Nephrology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy